A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: Evidence in support of routine ct surveillance

Journal of Thoracic Oncology

Volumn 9, Issue 8, 2014, Pages 1222-1225

  Griffioen, Gwendolyn H M J ^a   Lagerwaard, Frank J ^a   Haasbeek, Cornelis J A ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; ASPERGILLOSIS; BLOOD TRANSFUSION; CANCER CONTROL; CANCER STAGING; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEMOPTYSIS; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG EMBOLISM; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RESPIRATORY FAILURE; SECOND CANCER; SECONDARY INFECTION; STEREOTACTIC ABLATIVE RADIOTHERAPY; TOXICITY; ADVERSE EFFECTS; HEALTH SURVEY; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIATION PNEUMONITIS; RADIOGRAPHY; RADIOSURGERY; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEMOPTYSIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PNEUMONECTOMY; POPULATION SURVEILLANCE; RADIATION PNEUMONITIS; RADIOSURGERY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905865385     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000218     Document Type: Article

References (15)

1. Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg 2013;145:75-81; discussion 81.
2. Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al.; ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 (suppl 6):vi89-vi98.
3. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-38.
4. Furman MJ, Lambert LA, Sullivan ME, Whalen GF. Rational follow-up after curative cancer resection. J Clin Oncol 2013;31:1130-1133.
5. Mollberg NM, Ferguson MK. Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach. Ann Thorac Surg 2013;95:1112-1121.
6. Palma DA, Senan S. Improving outcomes for high-risk patients with earlystage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. Clin Lung Cancer 2013;14:1-5.
7. Chang JY, Liu YH, Zhu Z, et al. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer. Cancer 2013;119:3402-3410.
8. Creach KM, Bradley JD, Mahasittiwat P, Robinson CG. Stereotactic body radiation therapy in the treatment of multiple primary lung cancers. Radiother Oncol 2012;104:19-22.
9. Senthi S, Haasbeek CJ, Lagerwaard FJ, et al. Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. J Thorac Dis 2013;5:116-122.
10. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-smallcell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-692.
11. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:348-353.
12. Poghosyan H, Sheldon LK, Leveille SG, Cooley ME. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review. Lung Cancer 2013;81:11-26.
13. Hamaji M, Allen MS, Cassivi SD, et al. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg 2013;145:683-690; discussion 690.
14. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359:1388-1393.
15. Verstegen NE, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011;101:250-254.